Health-related quality of life in chronic liver disease: the impact of type and severity of disease ZM Younossi, N Boparai, LL Price, ML Kiwi, M McCormick, G Guyatt Official journal of the American College of Gastroenterology| ACG 96 (7 …, 2001 | 457 | 2001 |
Assessment of utilities and health-related quality of life in patients with chronic liver disease ZM Younossi, N Boparai, M McCormick, LL Price, G Guyatt Official journal of the American College of Gastroenterology| ACG 96 (2 …, 2001 | 200 | 2001 |
Impact of liver transplantation on health-related quality of life ZM Younossi, M McCormick, LL Price, N Boparai, L Farquhar, ... Liver transplantation 6 (6), 779-783, 2000 | 129 | 2000 |
A disease-specific health-realted quality of life instrument for chronic hepatitis C: CLDQ-HCV ZM Younossi, N Boparai, M McCormick Hepatology 32 (4), 369A-369A, 2000 | 10 | 2000 |
Impact of chronic liver disease on patients' utilities ZM Younossi, M McCormick, N Boparai, L Price, L Farquhar, G Guyatt Gastroenterology 116 (4), A1292-A1292, 1999 | 7 | 1999 |
Extensive evaluation of quality of life (QOL) in a large cohort of patients with a variety of chronic liver diseases ZM Younossi, N Bopurai, ML Kiwi, M McCormick, G Guyatt Hepatology 28 (4), 306A-306A, 1998 | 3 | 1998 |
Health-related quality of life in over 1000 patients with chronic liver disease: The impact of age, gender, culture, severity and type liver disease. ZM Younossi, G Marchesin, N Boparai, L Price, M McCormick Hepatology 30 (4), 484A-484A, 1999 | 2 | 1999 |
Health-related quality of life in hepatitis C measured by generic, disease-specific and utility instruments. ZM Younossi, M McCormick, N Boparai, L Price, G Guyatt Hepatology 30 (4), 686A-686A, 1999 | 1 | 1999 |
ORIGINAL CONTRIBUTIONS-OUTCOMES RESEARCH, GASTROINTESTINAL ONCOLOGY-Assessment of Utilities and Health-Related Quality of Life in Patients With Chronic Liver Disease ZM Younossi, N Boparai, M McCormick, LL Price, G Guyatt American Journal of Gastroenterology 96 (2), 579-583, 2001 | | 2001 |
Triple combination of interferon a-2b, ribavirin, and amantadine for treatment of chronic hepatitis C ZM Younossi, KD Mullen, S Hodnick, M McCormick, D Bringman, ... Gastroenterology 4 (118), A1501, 2000 | | 2000 |
Impact of Chronic Liver Disease on Patients' Utilities (Abstract# ZM Younossi, M McCormick, N Boparai, L Price, L Farquhar, G Guyatt GASTROENTEROLOGY-BALTIMORE THEN PHILADELPHIA- 116, L0496-L0496, 1999 | | 1999 |
Performance of new disease-specific quality of life instrument in cholestatic liver disease ZM Younossi, ML Kiwi, M McCormick, N Boparai, G Guyatt HEPATOLOGY 28 (4), 545A-545A, 1998 | | 1998 |
Can quality of life predict resource utilization in liver transplant candidates? ZM Younossi, N Boparai, ML Kiwi, L Farquhar, M McCormick, G Guyau HEPATOLOGY 28 (4), 741A-741A, 1998 | | 1998 |